Health Condition 1: K768- Other specified diseases of liver
Conditions
Interventions
None listed
Sponsors
Institute of Teaching and Research in Ayurveda, Jamnagar
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either sex of age group, 20 years to 60 years Both newly detected and previously diagnosed cases of Metabolic Dysfunction Associated Steatotic Liver Disease USG findings suggestive of fatty liver grade I & II Patients of Yakriddaalyudara (Metabolic Dysfunction-Associated Steatotic Liver Disease) with controlled blood pressure (100 to 140 mm of HG systolic and 80 to 90 mm of hg diastolic pressure) & Diabetic Mellitus (RBS 90 to 140 mg/dl)
Exclusion criteria
Exclusion criteria: Patient aged below 20 years and above 60 years pregnant women Patients with uncontrolled Diabetes or Hypertension Patients with complications of Metabolic syndrome like Cerebrovascular accident (CVA) Myocardial Infarction (MI) chronic kidney disease (CKD) Patients suffering from GB stone or obstructive jaundice Patients consuming Hepatotoxic medicines Alcohol or other Narcotic substances Patients suffering from Cirrhosis Ascites variceal hemorrhage Coagulopathy Hepato Renal Syndrome Patients having history of Viral hepatitis (HBsAg HCV) Autoimmune liver diseases (Primary biliary cirrhosis primary sclerosing cholangitis autoimmune hepatitis) Metabolic disorders (Wilsons disease haemochromatosis) congenital blood diseases (sickle cell disease thalassemia G6PD deficiency anemia etc) Patients suffering from HIV TB other infectious diseases Malignancies major psychiatric problems or any other serious illnesses Hb less then 10 gm %
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptomatic relief Pain intensity will be assessed using a 0 10 Visual Analogue (VA) Scale, where 0 indicates no pain and 10 indicates unimaginable and unspeakable pain. Intermediate scores represent increasing severity of pain, ranging from very light, barely noticeable pain (score 1), mild discomforting pain (score 2), noticeable pain adapted to by the patient (score 3), strong distressing pain (score 4), strong deep piercing pain affecting normal lifestyle (score 5), very strong pain interfering with work and daily activities (score 6), very strong deep piercing pain (score 7), very strong pain associated with severe personality changes when prolonged (score 8), and pain severe enough for the patient to demand analgesics or surgery regardless of risks (score 9).Timepoint: 1 MONTH | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in laboratory parameters & USG findings The clinical symptoms associated with fatty liver disease will be assessed using a symptom-based scoring system. The symptoms evaluated will include dyspepsia, nausea, malaise, fatigue, feeling of fullness in the abdomen, generalized weakness, & upper abdominal pain/discomfort. Each symptom will be scored as 0 when absent & 1 when present. The total symptom score will be calculated by summing the scores of all symptoms, with higher scores indicating greater symptom burden. Assessment will be carried out before & after treatment.Timepoint: 60 days | — |
Countries
India
Contacts
Public ContactDr Y R MEGHANI
nstitute of Teaching and Research in Ayurveda (ITRA) Jamnagar
Outcome results
None listed